HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin Kashima Selected Research

Sarcoidosis (Schaumann Disease)

1/2024Cardiac sarcoidosis in a patient with ulcerative colitis: A case report and literature review.
10/2021Development of pulmonary sarcoidosis in Crohn's disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin Kashima Research Topics

Disease

16Neoplasms (Cancer)
03/2024 - 08/2015
7Crohn Disease (Crohn's Disease)
01/2024 - 01/2013
6Stomach Neoplasms (Stomach Cancer)
03/2024 - 05/2012
6Ulcerative Colitis
01/2024 - 12/2015
6Colitis
01/2021 - 01/2013
5Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 01/2020
5Inflammation (Inflammations)
01/2022 - 09/2013
4Hemorrhage
05/2024 - 10/2011
4Adenocarcinoma
03/2024 - 01/2019
3Carcinoma (Carcinomatosis)
03/2024 - 09/2013
3Infections
07/2023 - 08/2010
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2018
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2024 - 06/2021
2Esophageal Neoplasms (Esophageal Cancer)
03/2024 - 06/2021
2Sarcoidosis (Schaumann Disease)
01/2024 - 10/2021
2Pathologic Constriction (Stenosis)
03/2022 - 01/2019
2Carcinogenesis
01/2021 - 05/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2024
1Weight Loss (Weight Reduction)
03/2024
1Latent Infection
07/2023
1Latent Tuberculosis
07/2023
1Atrial Fibrillation
10/2022
1Gastritis
07/2022
1Malnutrition (Nutritional Deficiencies)
03/2022
1Vomiting
03/2022
1Jaundice (Icterus)
01/2022
1Diverticular Diseases
01/2022
1Liver Diseases (Liver Disease)
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Chemical and Drug Induced Liver Injury
01/2022
1Frostbite
01/2022
1Cholestasis
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Wounds and Injuries (Trauma)
11/2021
1Pancreatitis
11/2021
1Pulmonary Sarcoidosis
10/2021
1Adenoma (Adenomas)
01/2021
1Precancerous Conditions
01/2021
1Colitis-Associated Neoplasms
01/2021
1Syncope (Fainting)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021
1Margins of Excision
09/2020
1Lymphatic Metastasis
01/2019
1Esophageal Stenosis (Esophageal Stricture)
01/2019
1Neoplasms, Cystic, Mucinous, and Serous
01/2018

Drug/Important Bio-Agent (IBA)

5PolyphosphatesIBA
11/2021 - 08/2015
4FerrichromeIBA
03/2024 - 06/2017
4Messenger RNA (mRNA)IBA
10/2022 - 01/2020
4Infliximab (Remicade)FDA Link
01/2022 - 01/2013
3Small Interfering RNA (siRNA)IBA
10/2022 - 06/2020
3Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
10/2022 - 01/2020
3Biomarkers (Surrogate Marker)IBA
08/2021 - 05/2012
3Proteins (Proteins, Gene)FDA Link
07/2021 - 03/2011
2carbazochrome (Adona)IBA
05/2024 - 10/2022
2Fluorouracil (Carac)FDA LinkGeneric
03/2024 - 01/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2023 - 01/2021
2Immune Checkpoint InhibitorsIBA
07/2022 - 01/2022
2NivolumabIBA
01/2022 - 01/2019
2Biosimilar PharmaceuticalsIBA
01/2022 - 10/2021
2CT-P13IBA
01/2022 - 10/2021
2SteroidsIBA
10/2021 - 01/2019
2AntibodiesIBA
07/2021 - 01/2021
2RNA-Binding Proteins (RNA-Binding Protein)IBA
06/2021 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2020
2Dextran SulfateIBA
01/2021 - 01/2021
2RibonucleoproteinsIBA
06/2020 - 01/2020
2Indicators and Reagents (Reagents)IBA
11/2017 - 12/2015
1lissamine rhodamine B (sulforhodamine B)IBA
03/2024
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2024
1pro-brain natriuretic peptide (1-76)IBA
01/2024
1vedolizumabIBA
07/2023
1Warfarin (Coumadin)FDA LinkGeneric
10/2022
1Heparin (Liquaemin)FDA LinkGeneric
10/2022
1CateninsIBA
01/2022
1Tumor Necrosis Factor InhibitorsIBA
01/2022
1pimonidazoleIBA
01/2022
1CeruletideIBA
11/2021
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
08/2021
1B7-H1 AntigenIBA
07/2021
1heptelidic acidIBA
01/2021
1Lidocaine (Xylocaine)FDA LinkGeneric
01/2021
1Octreotide (Sandostatin)FDA LinkGeneric
01/2021
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1p38 Mitogen-Activated Protein KinasesIBA
01/2021
1sphingosine 1-phosphate lyase (aldolase)IBA
06/2020
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
06/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Gastric MucinsIBA
01/2020
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2019

Therapy/Procedure

12Therapeutics
01/2024 - 08/2017
3Blood Component Removal (Apheresis)
01/2024 - 08/2021
3Remission Induction
01/2024 - 08/2021
3Drug Therapy (Chemotherapy)
01/2022 - 01/2019
1Gastrostomy
03/2022
1Punctures
03/2022
1Ligation
01/2022
1Gastrectomy
09/2020
1Surgical Instruments (Clip)
09/2020